Human Genome Sciences Reports Interim Results Of Phase 1b Clinical Trial Of HGS-ETR1 With Gemcitabine And Cisplatin Medical News Today
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that the interim results of a Phase 1b clinical trial demonstrate that HGS-ETR1 (mapatumumab) in combination with gemcitabine and cisplatin was well tolerated and could be administered safely and repetitively at the doses and schedules evaluated in patients with advanced solid tumors. [click link for full article]
Human Genome Drug Found Safe in Study AP via Yahoo! Finance
Biopharmaceutical company Human Genome Sciences Inc. said it will move on to midstage study of its cancer treatment candidate HGS-ETR1, or mapatumumab, after interim results from an earlier study found it to be safe and tolerable.
Human Genome 3rd-Quarter Loss Widens AP via Yahoo! Finance
Drug developer Human Genome Sciences Inc. on Wednesday posted a wider third-quarter loss, despite revenue gains on payments for codeveloping drugs.
Human Genome says cancer drug is safe Pharmaceutical Business Review
Human Genome Sciences has said a phase Ib clinical trial demonstrates that HGS-ETR1 in combination with gemcitabine and cisplatin was well tolerated and could be administered safely in patients with advanced solid tumors.
Human Genome Sciences Announces Financial Results for the Third Quarter of 2006 RedNova
ROCKVILLE, Md., Nov. 8 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced financial results for the quarter ended September 30, 2006.
Human Genome Sciences Reports Interim Results of Phase 1b Clinical Trial of HGS-ETR1 With Gemcitabine and Cisplatin in FinanzNachrichten
ROCKVILLE, Md., Nov. 8 /PRNewswire-FirstCall/ -- Human Genome Sciences, ( Nachrichten / Aktienkurs ) Inc. today announced that the interim results of a Phase 1b clinical trial demonstrate that HGS-ETR1 (mapatumumab) in combination with gemcitabine and cisplatin was well tolerated and could be administered safely and repetitively at the doses and schedules evaluated in patients with advanced solid
Human Genome drug found safe in study Sharewatch
In the Phase Ib clinical trial, the compound was administered in combination with two chemotherapy drugs. The data was taken from 32 patients with advanced solid tumors. Enrollment in the study is ongoing.
Human Genome 3rd-quarter loss widens Sharewatch
Quarterly losses totaled $60.8 million, or 46 cents per share, compared with a year-ago loss of $54.4 million, or 42 cents per share. The latest quarter includes stock-based compensation costs of 5 cents per share.
Noted biologist plans UCSD lab San Diego Union-Tribune
Biologist J. Craig Venter, whose role in the Human Genome Project brought him international fame and fortune, hopes to build a lab at UCSD for developing drugs from ocean microbes, the university's officials and researchers have confirmed.
HGS reports wider losses on accounting change bizjournals.com via Yahoo! Finance
Human Genome Sciences had higher quarterly revenue from drug development deals with pharmaceutical companies, but accounting changes led to wider third-quarter losses.

Genomics.energy.gov--genome programs of the U.S. Department of Energy
Site of the US Human Genome Project, Genomics:GTL Program, and Microbial Genome Program--all sponsored by the US Department of Energy Genome Programs.
The GDB Human Genome Database
The official central repository for genomic mapping data resulting from the Human Genome Initiative. Comprises descriptions of regions and maps of the human
The Human Transcript Map
The Human Genome Project is expected to produce a sequence of DNA representing the functional blueprint and evolutionary history of the human species.
genome.gov | All About The Human Genome Project (HGP)
Introduction to the Human Genome Project, published by the National Human Genome Research Institute. This brief overview is aimed at students, teachers and
Ensembl Genome Browser
Ensembl is a joint project between EMBL-EBI and the Sanger Centre to develop a software system which produces and maintains automatic annotation on

The Human Transcript Map
The Human Genome Project is expected to produce a sequence of DNA representing the functional blueprint and evolutionary history of the human species.
genome.gov | All About The Human Genome Project (HGP)
Introduction to the Human Genome Project, published by the National Human Genome Research Institute. This brief overview is aimed at students, teachers and
Ensembl Genome Browser
Ensembl is a joint project between EMBL-EBI and the Sanger Centre to develop a software system which produces and maintains automatic annotation on
Human genome - Wikipedia, the free encyclopedia
The human genome is composed of 23 pairs of chromosomes (46 in total), The human genome has many different regulatory sequences which are crucial to
the human genome
Explore how the 'book of life' has been decoded by the international Human Genome Project, and the impact of human genes on health, disease and society.
Human Genome Sciences
Human Genome Sciences is an emerging pharmaceutical company with the mission to predict, prevent, detect, treat and cure disease.
Science -- Human genome
The special issue on the first draft of the human genome.
UCSC Genome Browser Home
Provides genome browser, gene sorter, blat search function, and publications.